Logo image of CERO

CERO THERAPEUTICS HOLDINGS I (CERO) Stock Earnings & Estimates

NASDAQ:CERO - US71902K4022 - Common Stock

7.67 USD
-0.23 (-2.91%)
Last: 8/28/2025, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
CERO revenue by date.CERO revenue by date.
N/AN/AN/A
EBITDA
YoY % growth
CERO ebitda by date.CERO ebitda by date.
N/AN/AN/A-15.76MN/AN/AN/A
EBIT
YoY % growth
CERO ebit by date.CERO ebit by date.
-332K-2.905M
-775.12%		-2.933M
-0.95%		-16.198M
-452.27%		N/A
-12.42%		N/A
-20.22%		N/A
-64.23%
Operating Margin
CERO operating margin by date.CERO operating margin by date.
N/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CERO eps by date.CERO eps by date.
N/AN/AN/AN/AN/AN/A
38.38%		N/A
1.01%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-11.43-9.24-4.74
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/A
EBIT
Q2Q % growth		-4.452M
13.52%		-4.585M
-4.16%		-4.868M
-132.33%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth		 -28.80 -121.5892.7876.31%
CERO Yearly EPS VS EstimatesCERO Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -10 -20 -30
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -2014.15% 0% -384.16%
RevenueN/A N/A N/A N/A